Facilitating early detection and treatment
of prevalent, chronic and progressive
Meibomian Gland Disease (MGD).
Now you can easily visualize meibomian gland structure in seconds. And treat MGD effectively with the LipiFlow.
As a surgeon, I recognize the importance of optimizing the ocular surface and the long term consequences of not treating MGD...
MGD is a chronic, progressive disease affecting approximately 300 million people worldwide. MGD is characterized by terminal duct obstruction and/or changes in the glandular secretion.